Quilizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IGHE |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6492H10046N1728O2023S44 |
| Molar mass | 146082.49 g·mol−1 |
Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma. It binds to IGHE.
This drug was developed by Genentech.